Research and Markets: Gilead Sciences Clinical Development Profile 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/t4gpb2/gilead_sciences) has announced the addition of the "Gilead Sciences Clinical Development Profile" report to their offering.

With a market capitalization greater than $100B, Gilead is fast becoming one of the most influential pharmaceutical companies in the world. The report provides a thorough analysis of Gilead Sciences' R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Gilead's key products.

HOW YOU CAN USE THIS REPORT:

- Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar/ competing products.

- Service Providers: Better prepare your business development activities focused on Gilead. Understand their strategic direction, current and potential clinical development pipeline, and historic trial metrics.

Key Topics Covered:

1. Methodology and sources

2. Background and strategy

3. R&D pipeline overview

4. Clinical trial activity

5. Patents

6. FDA submissions

7. Key product profiles

7. Summary

For more information visit http://www.researchandmarkets.com/research/t4gpb2/gilead_sciences

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Drug Discovery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Drug Discovery